Improving the Standard of Care in Moderate to Severe Plaque Psoriasis and the Evolving Treatment Paradigm

November 29, 2023

Wednesday, November 29, 2023 at 2-3 pm ET            Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

Plaque psoriasis is a well-known, chronic, progressive, inflammatory disease that is associated with comorbidities, high economic burden and sequelae that impacts multiple aspects of patients’ lives. In recent decades, there has been significant clinical advancement in the treatments for moderate to severe plaque psoriasis with diverse modes of administration and mechanisms of action.

Despite the emergence of newer therapies, there remains an unmet need in psoriasis patients. Payers look to understand the goals for improving the standard of care and the value of treatments in the real-world beyond the outcomes achieved in clinical trials. There is an evolving treatment paradigm that models high levels of clinical disease improvement, lowers the economic burden of psoriasis and may reduce the patients’ risk for comorbid conditions.


  • Psoriasis is not just a skin disease but a systemic condition that is associated with increased risk for a number of comorbid conditions and sequelae.
  • As treatments advance, therapies are targeting more stringent clinical endpoints to achieve higher levels of disease control. However, a significant portion of patients are still not attaining treatment goals or have resolution of disease.
  • The goal of the evolving treatment paradigm is to gain early, tight disease control which can impact comorbidities, quality of life and disease manifestations outside skin involvement.

Learning Objectives

  • Understand the associated medical conditions of psoriasis and how the disease can affect multiple aspects of patients' lives.
  • Review the treatment targets for psoriasis and the unmet need in current treatment options.
  • Discuss the impact of the evolving treatment paradigm for plaque psoriasis and optimal characteristics of advanced therapies.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

For individuals from the media/press interested in attending, please email

Course summary
Course opens: 
Course expires: 
Event starts: 
11/29/2023 - 2:00pm EST
Event ends: 
11/29/2023 - 3:00pm EST


April Armstrong, MD, MPH
Chief and Professor of Dermatology
University of California, Los Angeles (UCLA)


Please login or register to take this course.